Delivery Order SPE2DB22D2206-SPE2DB25FEE40

Award Date 11/12/24
Potential Completion Date 12/4/24
Potential Value $8.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,491.60 fixed-price contract is for the delivery of the prescription medication PREVYMIS 480 MG TABLET 14S, with a completion date of May 30, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a $4,719.34 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PREVYMIS 480 MG TABLET 7S, a medication, with a performance period extending through June 25, 2025. The contract is not set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $4,580.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the medical product PREVYMIS 480 MG TABLET 7S, with a performance period ending on January 14, 2025. The contract is a firm-fixed-price arrangement, indicating a pre-determined payment structure for the delivered products. While the award itself does not...
This federal contract award, valued at $4,719.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The award covers the procurement of PREVYMIS 480 MG TABLET 7S, a pharmaceutical product, to support military...
This federal contract award is a delivery order valued at $4,719.34 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of PREVYMIS 480 MG TABLET 7S, a pharmaceutical product, with a period of performance extending through July 2, 2025. The contract is designated as non-set-aside, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award for $4,580.76 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the drug PREVYMIS 480 MG TABLET 7S, with a completion date of December 27, 2024. The contract is a firm-fixed price arrangement and does not have any set-aside designations. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,580.76 fixed-price delivery order covers the provision of PREVYMIS 480 MG TABLET 7S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for supplying...
This federal contract award, valued at $4,719.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PREVYMIS 480 MG TABLET 7S, a pharmaceutical product, with a performance period through June 4, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves...
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FF0NQ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,580.76 Firm Fixed Price Delivery Order Contract covers the provision of the drug PREVYMIS 480 MG TABLET 7S. This award is not designated as a set-aside. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The $4,719.34 firm fixed-price delivery order is for the supply of PREVYMIS 480 MG TABLET 7S medication, with a period of performance through July 7, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEE40
    Delivery Order

This federal contract award, valued at $8,855.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the prescription drug PREVYMIS 480 MG TABLET 7S. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition. The contract is a Firm Fixed Price arrangement, with an ultimate completion date of December 4, 2024.

Generated 2/11/25, 10:17 AM